LIMK1 is a promising therapeutic target for multiple pathologies. Its holistic study seems crucial, as none of its inhibitors has passed clinical trials. The need for new fluorescent probes for the study of enzyme/ligand interactions is always increasing with ... ...

请注册登录后继续浏览